We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+16.02%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$3.09B
AUM Growth
+$972M
(+46%)
Cap. Flow
+$684M
Cap. Flow
% of AUM
22.14%
Top 10 Holdings %
Top 10 Hldgs %
6.41%
Holding
2,561
New
545
Increased
906
Reduced
750
Closed
342
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$27.9M |
| 2 |
Humana
HUM
|
+$18.6M |
| 3 |
CMS Energy
CMS
|
+$17.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$15M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$92M |
| 2 |
Microsoft
MSFT
|
+$10.4M |
| 3 |
RTX Corp
RTX
|
+$10.3M |
| 4 |
Synopsys
SNPS
|
+$10.3M |
| 5 |
Weyerhaeuser
WY
|
+$9.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.11% |
| 2 | Technology | 15.39% |
| 3 | Healthcare | 12.56% |
| 4 | Financials | 10.75% |
| 5 | Industrials | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPFH
1926
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $137K | ﹤0.01% |
12,467
-51,186
| -80% | -$585K |
|
1927
KKR & Co
KKR
$92.3B
| $136K | ﹤0.01% |
5,792
-5,448
| -48% | -$124K |
|
1928
Acco Brands
ACCO
$407M
| $135K | ﹤0.01% |
15,726
-60,055
| -79% | -$525K |
|
1929
NatWest
NWG
$76.4B
| $135K | ﹤0.01% |
19,214
-38,854
| -67% | -$273K |
|
1930
Ingersoll Rand
IR
$33.7B
| $134K | ﹤0.01% |
4,834
-9,077
| -65% | -$228K |
|
|
WOW
1931
DELISTED
WideOpenWest
WOW
| $134K | ﹤0.01% |
14,696
-39,893
| -73% | -$326K |
|
1932
Criteo S.A. Ordinary Shares
CRTO
$923M
| $133K | ﹤0.01% |
+6,617
| New | +$169K |
|
|
AMRN
1933
Amarin Corp
AMRN
$303M
| $132K | ﹤0.01% |
318
-736
| -70% | -$265K |
|
1934
Axogen
AXGN
$2.5B
| $131K | ﹤0.01% |
+6,225
| New | +$114K |
|
1935
Barnes & Noble Education
BNED
$443M
| $131K | ﹤0.01% |
313
-423
| -57% | -$229K |
|
1936
Global Net Lease
GNL
$1.95B
| $131K | ﹤0.01% |
6,943
-20,251
| -74% | -$386K |
|
1937
RPC Inc
RES
$1.3B
| $130K | ﹤0.01% |
+11,423
| New | +$122K |
|
|
TMHC
1938
DELISTED
Taylor Morrison
TMHC
| $129K | ﹤0.01% |
7,291
+3,657
| +101% | +$65.3K |
|
|
CNCE
1939
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $129K | ﹤0.01% |
+10,672
| New | +$157K |
|
1940
Ambev
ABEV
$46.4B
| $128K | ﹤0.01% |
29,660
-14,051
| -32% | -$64.5K |
|
1941
Aclaris Therapeutics
ACRS
$825M
| $127K | ﹤0.01% |
21,148
-64,914
| -75% | -$430K |
|
1942
Guardant Health
GH
$22.6B
| $127K | ﹤0.01% |
+1,662
| New | +$92.1K |
|
|
FLXN
1943
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $127K | ﹤0.01% |
10,154
+8,313
| +452% | +$111K |
|
|
TNAV
1944
DELISTED
Telenav Inc.
TNAV
| $127K | ﹤0.01% |
+20,848
| New | +$110K |
|
|
ENDP
1945
DELISTED
Endo International plc
ENDP
| $125K | ﹤0.01% |
15,545
-365,163
| -96% | -$3.43M |
|
1946
Crane NXT
CXT
$3.07B
| $124K | ﹤0.01% |
4,235
-48,615
| -92% | -$1.38M |
|
1947
ADT
ADT
$5.58B
| $123K | ﹤0.01% |
19,185
+7,440
| +63% | +$53.7K |
|
1948
Graphic Packaging
GPK
$3.58B
| $123K | ﹤0.01% |
+9,762
| New | +$119K |
|
|
EARN
1949
Ellington Residential Mortgage REIT
EARN
$165M
| $122K | ﹤0.01% |
10,227
| – | – |
|
|
HTBK
1950
DELISTED
Heritage Commerce
HTBK
| $122K | ﹤0.01% |
+10,066
| New | +$131K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2019 Portfolio in Review
As of Q1 2019, Cubist Systematic Strategies held 2,561 positions worth $3.09B, up 46% from $2.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Cubist Systematic Strategies deployed $684M of net new capital in Q1 2019, opening 545 new positions and adding to 906 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92M trimmed.
- Cubist Systematic Strategies's largest Q1 2019 buy was Arthur J. Gallagher & Co: 175,587 shares worth $13.7M.
- Cubist Systematic Strategies added most to ConocoPhillips in Q1 2019, an estimated $27.9M increase.
- Cubist Systematic Strategies's biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92M.
- Cubist Systematic Strategies fully exited Nasdaq in Q1 2019, selling an estimated $6.35M.
- Cubist Systematic Strategies's ten largest holdings make up 6.4% of its $3.09B portfolio in Q1 2019.
- Cubist Systematic Strategies opened 545 new positions and closed 342 in Q1 2019.
- Cubist Systematic Strategies's portfolio value rose 46% quarter-over-quarter to $3.09B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2019, filed 15 May 2019.